Literature DB >> 12574951

Glaucomatous visual field defects in patients with migraine.

Selçuk Comoğlu1, Alper Yarangümeli, Ozlem Gürbüz Köz, Atilla Halil Elhan, Gülcan Kural.   

Abstract

PURPOSE: To investigate the visual fields in patients with migraine in terms of glaucomatous visual field defects.
METHOD: Patients who attended our Neurology outpatient clinic complaining of headache and were diagnosed as migraine were enrolled in the study. Each patient was questioned for the frequency, side, localisation and severeness of the pain as well as the onset and the duration of the symptoms, the existence of aura, the description of the aura - if present -, additional systemic problems, and family history of migraine and glaucoma. Detailed ophthalmological examinations and computerised visual field (VF) analysis were then performed on each patient in our Ophthalmology Clinic. The findings of 77 patients (61 female, 16 male) were evaluated and statistical comparisons were carried out between the group of patients with glaucomatous-like VF defects and the group without significant defects.
RESULTS: VF tests revealed glaucomatous-like defects in 48 (62.3 %) patients. Intraocular pressure (IOP) levels were within normal limits in all cases. There were no statistically significant differences between the groups with and without VF defects in terms of sex, the localisation and severeness of pain, the existence and the description of aura, and family history of glaucoma, as well as the duration of migraine, IOP and cup/disc ratio. The glaucomatous group was significantly older, with a significantly higher age of onset for migraine. Risk of having glaucomatous-like defects was higher in patients who had migraine attacks once a month or less frequently. A tendency of pain and VF defects to develop ipsilaterally was noticed. DISCUSSION: A possible relationship between the pathophysiology of migraine, visual field defects and glaucomatous optic neuropathy is emphasized and VF screening for normal tension glaucoma is recommended in patients with migraine.

Entities:  

Mesh:

Year:  2003        PMID: 12574951     DOI: 10.1007/s00415-003-0975-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  5 in total

1.  Topical beta-blocker treatment for migraine.

Authors:  Patrick J T Chiam
Journal:  Int Ophthalmol       Date:  2012-01-26       Impact factor: 2.031

Review 2.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

3.  Visual Field Losses in Patients with Migraine without Aura and Tension-Type Headache.

Authors:  Arif Ü Yener; Osman Korucu
Journal:  Neuroophthalmology       Date:  2017-01-11

4.  Migraine increases centre-surround suppression for drifting visual stimuli.

Authors:  Josephine Battista; David R Badcock; Allison M McKendrick
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

5.  Ocular Pressure-Volume Relationship and Ganglion Cell Death in Glaucoma.

Authors:  Ji-Jie Pang; Samuel M Wu
Journal:  OBM Neurobiol       Date:  2021-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.